Biomedical Technologies (BT), now part of Alfa Aesar, specializes in the production of high quality lipoprotein reagents for cardiovascular disease research. We offer native human lipoproteins, and also oxidized, acetylated or carbamylated low density lipoproteins. Additionally, we provide fluorescently labelled lipoproteins. These fluorescent reagents conveniently label cultured cells for identification, isolation or quantification of receptor site activity. All of our lipoproteins are membrane filtered and aseptically filled, and some are endotoxin tested.
BT has been manufacturing life science research products for more than 30 years and has brought protein research and characterization to our product offering.
Website : www.alfa.com
Polyclonal anti-mouse unconjugated primary antibodies
H. T. Preis